Skip to main content
. 2019 Apr 7;2019:6180236. doi: 10.1155/2019/6180236

Table 2.

Clinical signs in male mice after 2 weeks of repeated oral administration of MO.

Group (mg/kg/day) Days after treatment
1 2 3 4 5 6 7 8 9 10 11 12 13 14
0 ∗0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5
50 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5
150 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5
450 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5

∗Number of mice with clinical signs/total mice.